entity

ALS-FTD

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ALS-FTD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections
1Hypotheses
1Analyses
0Outgoing
8Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Novel Therapy Index

idea · 10647 words

Parkinson's Disease

disease · 8807 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (8)

SourceRelationTypeStr
Loss Of TDP-43 Splicing Repressionassociated_withmechanism0.95
TDP-43associated_withprotein0.95
TARDBPassociated_withprotein0.95
Cryptic HDGFL2biomarker_forbiomarker0.93
C9ORF72risk_factor_forgene0.92

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Stathmin-2 Splice Switching to Prevent Axonal Degeneration A 0.664 neurodegeneration RNA binding protein dysregulation across

Mentioning Analyses (1)

Scientific analyses that reference this entity

TDP-43 phase separation therapeutics for ALS-FTD

neurodegeneration | 2026-04-01 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found